Investigator

K. N. Ncube

Lecturer · University of Pretoria, Pharmacology

About

KNNK. N. Ncube
Papers(1)
Advancing cervical ca…
Collaborators(3)
M. T. LebeloS. P. MathibelaV. Steenkamp
Institutions(2)
Unknown InstitutionUniversity of Pretoria

Papers

Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology

Abstract Background Cervical cancer remains a major global health challenge, with the highest incidence and mortality rates observed in sub-Saharan Africa. Despite progress in prevention and treatment, the management of advanced and recurrent disease remains difficult. Aim This review explores the potential role of cannabinoids in cervical cancer therapy, with a focus on their integration into existing treatment strategies, combination therapies, and nanotechnology-based delivery systems. Methods A critical synthesis of preclinical studies and emerging therapeutic approaches was conducted, examining the anticancer properties of cannabinoids, their mechanisms of action, and their application within combination and nanotechnology-based treatment modalities. Results Cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) demonstrate anticancer effects by inducing apoptosis, inhibiting cell proliferation, and suppressing metastasis. Mechanistic studies highlight their ability to promote oxidative stress, modulate key signalling pathways, and influence immune responses in cervical cancer cells. Combination therapies involving cannabinoids with chemotherapy, radiotherapy, and immunotherapy show enhanced efficacy and reduced drug resistance. Furthermore, nanotechnology-based delivery systems offer advantages including targeted drug release, improved solubility, controlled dosing, and decreased systemic toxicity. Conclusion Cannabinoids represent a promising adjunct in cervical cancer management. However, successful clinical translation requires optimisation of formulations, establishment of dosing protocols, and comprehensive safety evaluation. Future research should also explore biomarker-driven personalised medicine approaches. Standardisation, along with addressing regulatory and ethical challenges, will be crucial for the integration of cannabinoid-based therapies into mainstream cervical cancer treatment.

11Works
1Papers
3Collaborators
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsDrug Resistance, Neoplasm

Positions

2022–

Lecturer

University of Pretoria · Pharmacology

2021–

Technical assistant

University of Pretoria · Pharmacology

2021–

Blogger

South African Young Academy of Sciences (SAYAS) · Department of Science and Technology

2018–

Tutor and teaching assistant

University of Pretoria · Pharmacology

2017–

Tutor

University of Pretoria · Chemistry

2014–

Laboratory demonstrator

University of Pretoria · Chemistry

2015–

Teaching assistant

University of Pretoria · BIochemistry

Education

2019

Masters in Pharmacology (Magna cum laude)

University of Pretoria · Pharmacology

2016

BSc Honors Pharmacology (Awarded with distinction)

University of Pretoria · Pharmacology

2015

BSc Medical Science (Awarded with distinction)

University of Pretoria · Department of Anatomy

Country

ZA

Links & IDs